Nuevo conocimiento - FVL

URI permanente para esta colecciónhttp://hdl.handle.net/10906/81422

Examinar

Mostrando 1 - 2 de 2

Terapia con anticuerpos monoclonales en Cardiología y Medicina Interna
(Sociedad Colombiana de Cardiologia, 2016-07-12) Adams Sánchez, Christian David
The monoclonal antibodies (mAb) constitute a new therapeutic tool in cardiovascular medicine, based in the development of the molecular biology in this area. The understanding of therapeutic principles, types and mechanism of action of these drugs is essential for proper use and management of adverse reactions. We discuss the profile of the PCSK-9 inhibitors, the Dabigatran antidote, the abciximab, the digoxin antidote, the therapy in heart transplantation, and a possible cardiovascular use of monoclonal antibodies used in rheumatology.
Xpert (R) MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns
(International Union Against Tuberculosis and Lung Disease, 2015-07-01) Martínez, Luisa F
Globally, one in three individuals harbours Myco-bacterium tuberculosis (TB) inside their bodies; thepresence of M. tuberculosis DNA in a person does not mean TB disease.